Mann, CLA; Davies, MB; Stevenson, VL; Leary, SM; Boggild, MD; Ko, CK; ... Hawkins, CP; + view all Mann, CLA; Davies, MB; Stevenson, VL; Leary, SM; Boggild, MD; Ko, CK; Jones, PW; Fryer, AA; Strange, RC; Thompson, AJ; Hawkins, CP; - view fewer (2002) Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J NEUROIMMUNOL , 129 (1-2) 197 - 204.
Full text not available from this repository.
We studied the association between clinical outcome in MS and allelic variants single nucleotide polymorphisms (SNPs) of interleukin-1alpha (IL-1alpha), IL-1beta and a variable number tandem repeat (VNTR) in IL-1 receptor antagonist (IL-1RN). A total of 377 patients with MS were studied. Significant associations between IL-1 genotypes and clinical outcome were found using logistic regression after correction for gender, onset age and disease duration. The same trends were subsequently demonstrated in a second independent group of 67 primary progressive patients. Our results suggest that genetically determined immunomodulation mediated by IL-1 influences long-term prognosis in multiple sclerosis (MS). (C) 2002 Elsevier Science B.V. All rights reserved.
|Title:||Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity|
|Keywords:||multiple sclerosis, interleukin-1, interleukin-1 receptor antagonist, severity, linkage disequilibrium, SNP, RECEPTOR ANTAGONIST IL-1RA, BLOOD-BRAIN-BARRIER, GENETIC ASSOCIATION, CRYSTAL-STRUCTURE, POLYMORPHISM, MS, MRI, SUSCEPTIBILITY, MARKERS, CLUSTER|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Brain Sciences|
Archive Staff Only: edit this record